drug · small molecule
olomorasib
Phase 3updated 3mo agoby Eli Lilly and Co🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1 (across all indications), with 3 investigational indications.
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying olomorasib
- phase3Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- phase1A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
- phase2A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
- phase1A Study of Olomorasib (LY3537982) in Healthy Participants
- phase1A Study of Olomorasib (LY3537982) in Healthy Japanese Participants
- phase1A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that